FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973063054> ?p ?o ?g. }

• W1973063054 endingPage "18" @default.
• W1973063054 startingPage "10" @default.
• W1973063054 abstract "Mucin-1 (MUC-1), which is overexpressed in more than 90% of human breast cancers, is a potential target for immunotherapy. To develop a mouse model appropriate for the immunotherapy of human cancer, mouse mucin-1 (muc-1) fusion protein, containing ten tandem repeats, was made and used to immunize C3H/HeOuj mice, which supposedly have a high incidence of breast cancer. C3H/HeOuj mice were injected eight times with 5 μg oxidized mannan muc-1–glutathione-S-transferase (MMFP) with or without cyclophosphamide, which is used to increase cellular immunity. At 80 age weeks, only 12.1% (4 of 33) mice of the untreated C3H/HeOuj mice had mammary tumors. The reason for the low incidence of breast cancer in these mice is not known, but all the mammary tumors were MUC-1+ breast adenocarcinomas and were transplantable to C3H/HeOuj mice. The incidence was 11.4% (4 of 35) in mice injected with MMFP; 38.2% (13 of 34) in mice given cyclophosphamide; and 14.3% (2 of 14) in mice treated with glutathione-S-transferase. That is, cyclophosphamide increased the incidence of mammary tumors, and metastases were found in only these mice. Fewer tumors (6 of 34 or 17.6% compared with 13 of 34 or 38.2% with cyclophosphamide only) occurred in the group immunized with MMFP and cyclophosphamide. Mice immunized with MMFP had high levels of muc-1 antibodies and cellular immune responses (the frequency of the precursor of the cytotoxic T-lymphocyte cell was 1 of 40,000 to 1 of 100,000), which were not found in control groups. The occurrence of muc-1 immunity, particularly the presence of large amounts of anti–mucin-1 antibodies, had no effect on tumor incidence. Thus, the immunization with murine muc-1 reduced the tumor incidence in only cyclophosphamide-treated mice and led to strong muc-1 antibody production and to cellular responses. These findings have implications for human tumor immunotherapy in which strong antibody and weak cellular responses are to be expected and, indeed, have been found." @default.
• W1973063054 created "2016-06-24" @default.
• W1973063054 creator A5026988621 @default.
• W1973063054 creator A5054416511 @default.
• W1973063054 creator A5082538834 @default.
• W1973063054 date "2001-01-01" @default.
• W1973063054 modified "2023-09-27" @default.
• W1973063054 title "Breast Cancer in Mice: Effect of Murine Muc-1 Immunization on Tumor Incidence in C3H/HeOuj Mice" @default.
• W1973063054 cites W1617102100 @default.
• W1973063054 cites W1909617247 @default.
• W1973063054 cites W1967524316 @default.
• W1973063054 cites W1979397217 @default.
• W1973063054 cites W1989686184 @default.
• W1973063054 cites W1989819045 @default.
• W1973063054 cites W2004292912 @default.
• W1973063054 cites W2010427283 @default.
• W1973063054 cites W2059833802 @default.
• W1973063054 cites W2067267566 @default.
• W1973063054 cites W2073788351 @default.
• W1973063054 cites W2074453811 @default.
• W1973063054 cites W2081268598 @default.
• W1973063054 cites W2084985983 @default.
• W1973063054 cites W2167798268 @default.
• W1973063054 doi "https://doi.org/10.1097/00002371-200101000-00002" @default.
• W1973063054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11211144" @default.
• W1973063054 hasPublicationYear "2001" @default.
• W1973063054 type Work @default.
• W1973063054 sameAs 1973063054 @default.
• W1973063054 citedByCount "5" @default.
• W1973063054 countsByYear W19730630542022 @default.
• W1973063054 crossrefType "journal-article" @default.
• W1973063054 hasAuthorship W1973063054A5026988621 @default.
• W1973063054 hasAuthorship W1973063054A5054416511 @default.
• W1973063054 hasAuthorship W1973063054A5082538834 @default.
• W1973063054 hasBestOaLocation W19730630541 @default.
• W1973063054 hasConcept C121608353 @default.
• W1973063054 hasConcept C126322002 @default.
• W1973063054 hasConcept C154317977 @default.
• W1973063054 hasConcept C202751555 @default.
• W1973063054 hasConcept C203014093 @default.
• W1973063054 hasConcept C2776694085 @default.
• W1973063054 hasConcept C2776755627 @default.
• W1973063054 hasConcept C2777701055 @default.
• W1973063054 hasConcept C2778001805 @default.
• W1973063054 hasConcept C502942594 @default.
• W1973063054 hasConcept C530470458 @default.
• W1973063054 hasConcept C55493867 @default.
• W1973063054 hasConcept C71924100 @default.
• W1973063054 hasConcept C86803240 @default.
• W1973063054 hasConcept C8891405 @default.
• W1973063054 hasConceptScore W1973063054C121608353 @default.
• W1973063054 hasConceptScore W1973063054C126322002 @default.
• W1973063054 hasConceptScore W1973063054C154317977 @default.
• W1973063054 hasConceptScore W1973063054C202751555 @default.
• W1973063054 hasConceptScore W1973063054C203014093 @default.
• W1973063054 hasConceptScore W1973063054C2776694085 @default.
• W1973063054 hasConceptScore W1973063054C2776755627 @default.
• W1973063054 hasConceptScore W1973063054C2777701055 @default.
• W1973063054 hasConceptScore W1973063054C2778001805 @default.
• W1973063054 hasConceptScore W1973063054C502942594 @default.
• W1973063054 hasConceptScore W1973063054C530470458 @default.
• W1973063054 hasConceptScore W1973063054C55493867 @default.
• W1973063054 hasConceptScore W1973063054C71924100 @default.
• W1973063054 hasConceptScore W1973063054C86803240 @default.
• W1973063054 hasConceptScore W1973063054C8891405 @default.
• W1973063054 hasIssue "1" @default.
• W1973063054 hasLocation W19730630541 @default.
• W1973063054 hasLocation W19730630542 @default.
• W1973063054 hasOpenAccess W1973063054 @default.
• W1973063054 hasPrimaryLocation W19730630541 @default.
• W1973063054 hasRelatedWork W1996150995 @default.
• W1973063054 hasRelatedWork W2137656917 @default.
• W1973063054 hasRelatedWork W2365277249 @default.
• W1973063054 hasRelatedWork W2380201224 @default.
• W1973063054 hasRelatedWork W2489068520 @default.
• W1973063054 hasRelatedWork W3009386543 @default.
• W1973063054 hasRelatedWork W3180780036 @default.
• W1973063054 hasRelatedWork W4214554217 @default.
• W1973063054 hasRelatedWork W4291367166 @default.
• W1973063054 hasRelatedWork W4360983034 @default.
• W1973063054 hasVolume "24" @default.
• W1973063054 isParatext "false" @default.
• W1973063054 isRetracted "false" @default.
• W1973063054 magId "1973063054" @default.
• W1973063054 workType "article" @default.